The currently recommended vaccine—RTS,S—functions by targeting the Plasmodium falciparum circumsporozoite protein (CSP), which is the most abundant surface protein of the sporozoite form responsible for initiating infection of the human host. This evidence concerns the gene ERVW-1 and infection.